Integrated clinical and specialty pharmacy practice model for management of patients with multiple sclerosis

Hanson, Rebekah L.; Habibi, Mitra; Khamo, Nehrin W.; Abdou, Sherif; Stubbings, JoAnn

doi:10.2146/ajhp130495

Cited by 54 publications

(32 citation statements)

References 7 publications

(15 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[47][48][49] These new outpatient operations have the potential for improved medication access for patients, better continuity of care and integration, improved patient outcomes, and a new revenue stream for the health system. Since most specialty drugs are still widely available to hospitals and clinics, opportunities exist for outpatient specialty pharmacies in therapeutic categories that are relevant to the health system, such as oncology, inflammatory conditions, multiple sclerosis, transplant, and infectious disease.…”

Section: Discussionmentioning

confidence: 99%

National trends in prescription drug expenditures and projections for 2015

Schumock

Suda

et al. 2015

American Journal of Health-System Pharmacy

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

National trends in prescription drug expenditures and projections for 2015

Schumock

Suda

et al. 2015

American Journal of Health-System Pharmacy

Self Cite

View full text Add to dashboard Cite

show abstract

“…2 The advancements in treatment options for MS has drastically increased the time providers must allocate to medication management. 3,4 Most DMTs are classified as specialty medications because of their cost, medication access restrictions, specialized administration training and requirements for ongoing monitoring. With the cost of DMTs increasing at an exponential rate, coverage denials are occurring more frequently, often requiring multiple steps for medication approval.…”

Section: Introductionmentioning

confidence: 99%

“…5 The complexity of this process and the substantial amount of time required for medication management necessitates the involvement of a medication expert, such as a clinical pharmacist, in MS patient care. 3,5 Historically, there was no formal process dedicated to medication therapy management (MTM) for patients with MS seen at the Grady Health System (GHS) neurology clinic.…”

Section: Introductionmentioning

confidence: 99%

Incorporation and Impact of a Clinical Pharmacist in a Hospital-Based Neurology Clinic Treating Patients with Multiple Sclerosis

May¹,

Morgan²,

Quairoli³

2020

International Journal of MS Care

View full text Add to dashboard Cite

Background: Clinical pharmacists are uniquely positioned to assist with the complexities of medication management for patients with multiple sclerosis (MS). The objective of this study is to describe clinical pharmacy services provided as well as provider satisfaction and perceived impact of incorporating a clinical pharmacist in MS patient care. Methods: This study was conducted in two parts: a retrospective chart review and provider survey conducted in an outpatient neurology clinic at an academic medical center. Between April 2017 and June 2018, electronic medical records (EMRs) of patients with documented interventions by a pharmacist were reviewed to describe clinical pharmacy services provided to MS patients. A voluntary, anonymous survey was distributed to neurology providers to evaluate provider satisfaction and perceived impact of clinical pharmacist involvement in MS patient care. Results: There were 64 patients identified during the study period with 378 documented interventions made by clinical pharmacists. Pharmacist interventions were most commonly related to facilitating medication access (N=208), pre-treatment screening (N=57), patient counseling (N=51), and providing drug information (N=43). All providers surveyed (n=9) indicated that facilitating medication access, patient counseling, and drug interaction management were moderately or very important clinical pharmacy services. Furthermore, all providers surveyed strongly agreed that pharmacist involvement decreased time to therapy initiation for patients and decreased provider time spent on medication management. Conclusions: Clinical pharmacists play an integral role in MS patient care, particularly with facilitating medication access. Prospective studies are needed to further evaluate the contribution of clinical pharmacists in the care of MS patients.

show abstract

“…A growing number of health systems have developed internal specialty pharmacies to alleviate barriers to accessing specialty medications, improve appropriate utilization and optimization of specialty agents, and streamline transitions in care [13][14][15][16][17]. Several studies have demonstrated the benefit of pharmacists in maintaining continuity of care for patients transitioning from one healthcare setting to another [18,19].…”

Section: Introductionmentioning

confidence: 99%

An Integrated Health-System Specialty Pharmacy Model for Coordinating Transitions of Care: Specialty Medication Challenges and Specialty Pharmacist Opportunities

et al. 2019

View full text Add to dashboard Cite

Adherence and persistence to specialty medications are necessary to achieve successful outcomes of costly therapies. The increasing use of specialty medications has exposed several unique barriers to certain specialty treatments’ continuation. Integrated specialty pharmacy teams facilitate transitions in sites of care, between different provider types, among prescribed specialty medications, and during financial coverage changes. We review obstacles encountered within these types of transitions and the role of the specialty pharmacist in overcoming these obstacles. Case examples for each type of specialty transition provide insight into the unique complexities faced by patients, and shed light on pharmacists’ vital role in patient care. This insightful and real-world experience is needed to facilitate best practices in specialty care, particularly in the growing number of health-system specialty pharmacies.

show abstract

Integrated clinical and specialty pharmacy practice model for management of patients with multiple sclerosis

Abstract: An integrated pharmacy practice model that includes an interdisciplinary team of physicians, nurses, and pharmacists improved patient compliance with MS therapies.

Cited by 54 publications

References 7 publications

National trends in prescription drug expenditures and projections for 2015

National trends in prescription drug expenditures and projections for 2015

Incorporation and Impact of a Clinical Pharmacist in a Hospital-Based Neurology Clinic Treating Patients with Multiple Sclerosis

An Integrated Health-System Specialty Pharmacy Model for Coordinating Transitions of Care: Specialty Medication Challenges and Specialty Pharmacist Opportunities

Contact Info

Product

Resources

About